IRCT20220211053992N33招募中Unknown
In vivo fasted-state bioequivalence study of Rosuvastatin 40 mg tablet manufactured by Sobhan Pharmaceutical Co. compared to innovator product
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- All
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
不适用
Investigating In vivo Bioequivalence of Rosuvastatin TabletIRCT20210519051345N11Tabriz University of Medical Sciences24
招募中
Unknown
Bioequivalence study of Rivaroxaban 20 mg tabletIRCT20210519051345N59Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Evererolimus tabletsIRCT20220211053992N31Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N32Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Levodopa/benserazide tabletsIRCT20220211053992N34Tabriz University of Medical Sciences24